BioCryst Reports Second Quarter 2014 Financial Results

Go back to BioCryst Reports Second Quarter 2014 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.64 +0.14 (1.65%)
Previous Close $8.50    52 Week High $10.98 
Open $8.47    52 Week Low $1.63 
Day High $8.70    P/E N/A 
Day Low $8.45    EPS $-0.68 
Volume 594,587